AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial
Investing.com· Reuters· Aug 27, 2026 · 12:00 PM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocksabout 1 hour ago
J.B. Hunt stock plunges 10% after company warns third-quarter earnings will fall
Shares of J.B. Hunt plunged more than 10% Wednesday after the company warned of an earnings drop between 5% and 10%.
CNBC Stocks
stocksabout 1 hour ago
Why is CoreWeave stock climbing today?
Investing.com
stocksabout 1 hour ago
Sling Therapeutics raises $123m for thyroid eye disease drug trial
Investing.com